Literature DB >> 7986365

Lesions of the pontine parabrachial nuclei eliminate successive negative contrast effects in rats.

P S Grigson1, A C Spector, R Norgren.   

Abstract

Rats shifted from a high to a low concentration of sucrose make fewer licks for the low concentration than rats that experience only the low concentration of sucrose. This phenomenon, referred to as successive negative contrast, is eliminated after bilateral electrolytic lesions of the amygdala. Because the amygdala receives direct projections from the gustatory zone of the parabrachial nuclei of the pons (PBN), this experiment was designed to examine this phenomenon in rats with electrophysiologically guided bilateral electrolytic lesions of the PBN. The results of this experiment showed that lesions of the PBN fully prevent contrast in rats shifted from the high to the low concentration of sucrose. Thus, an intact PBN is essential for the occurrence of successive negative contrast effects in rats.

Entities:  

Mesh:

Year:  1994        PMID: 7986365     DOI: 10.1037//0735-7044.108.4.714

Source DB:  PubMed          Journal:  Behav Neurosci        ISSN: 0735-7044            Impact factor:   1.912


  4 in total

1.  Relative reward effects on operant behavior: Incentive contrast, induction and variety effects.

Authors:  E S Webber; N E Chambers; J A Kostek; D E Mankin; H C Cromwell
Journal:  Behav Processes       Date:  2015-05-12       Impact factor: 1.777

2.  Behavioral analyses of taste function and ingestion in rodent models.

Authors:  Alan C Spector
Journal:  Physiol Behav       Date:  2015-04-16

3.  Contexts control negative contrast and restrict the expression of flavor preference conditioning.

Authors:  Joseph M Austen; David J Sanderson
Journal:  J Exp Psychol Anim Learn Cogn       Date:  2016-01       Impact factor: 2.478

4.  Striatal Activity and Reward Relativity: Neural Signals Encoding Dynamic Outcome Valuation.

Authors:  Emily S Webber; David E Mankin; Howard C Cromwell
Journal:  eNeuro       Date:  2016-11-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.